These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 31821443)

  • 1. Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion.
    Broggi A; Granucci F; Zanoni I
    J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31821443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces.
    Stanifer ML; Guo C; Doldan P; Boulant S
    Front Immunol; 2020; 11():608645. PubMed ID: 33362795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpesviruses and the Type III Interferon System.
    Yin Y; Favoreel HW
    Virol Sin; 2021 Aug; 36(4):577-587. PubMed ID: 33400088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III Interferon Restriction by Porcine Epidemic Diarrhea Virus and the Role of Viral Protein nsp1 in IRF1 Signaling.
    Zhang Q; Ke H; Blikslager A; Fujita T; Yoo D
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases.
    Wallace JW; Constant DA; Nice TJ
    Front Immunol; 2021; 12():767505. PubMed ID: 34712246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both type I and type III interferons are required to restrict measles virus growth in lung epithelial cells.
    Taniguchi M; Yanagi Y; Ohno S
    Arch Virol; 2019 Feb; 164(2):439-446. PubMed ID: 30390151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells.
    Doldan P; Dai J; Metz-Zumaran C; Patton JT; Stanifer ML; Boulant S
    J Virol; 2022 Sep; 96(17):e0070622. PubMed ID: 36000839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
    Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
    J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Effects of Type I and III Interferons on Enteric Viruses.
    Ingle H; Peterson ST; Baldridge MT
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29361691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-λ in the context of viral infections: production, response and therapeutic implications.
    Hermant P; Michiels T
    J Innate Immun; 2014; 6(5):563-74. PubMed ID: 24751921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons.
    Forero A; Ozarkar S; Li H; Lee CH; Hemann EA; Nadjsombati MS; Hendricks MR; So L; Green R; Roy CN; Sarkar SN; von Moltke J; Anderson SK; Gale M; Savan R
    Immunity; 2019 Sep; 51(3):451-464.e6. PubMed ID: 31471108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs.
    Zanoni I; Granucci F; Broggi A
    Front Immunol; 2017; 8():1661. PubMed ID: 29234323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines.
    Ye L; Ohnemus A; Ong LC; Gad HH; Hartmann R; Lycke N; Staeheli P
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudorabies virus-induced expression and antiviral activity of type I or type III interferon depend on the type of infected epithelial cell.
    Yin Y; Ma J; Van Waesberghe C; Devriendt B; Favoreel HW
    Front Immunol; 2022; 13():1016982. PubMed ID: 36405751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared and Distinct Functions of Type I and Type III Interferons.
    Lazear HM; Schoggins JW; Diamond MS
    Immunity; 2019 Apr; 50(4):907-923. PubMed ID: 30995506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type III interferon is a critical regulator of innate antifungal immunity.
    Espinosa V; Dutta O; McElrath C; Du P; Chang YJ; Cicciarelli B; Pitler A; Whitehead I; Obar JJ; Durbin JE; Kotenko SV; Rivera A
    Sci Immunol; 2017 Oct; 2(16):. PubMed ID: 28986419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons.
    Jafarzadeh A; Nemati M; Saha B; Bansode YD; Jafarzadeh S
    Viral Immunol; 2021 Jun; 34(5):307-320. PubMed ID: 33147113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.